Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
21,96 USD | +1,83% |
|
+2,70% | -30,03% |
Attività
Numero di dipendenti: 180
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Nucleic Acid-focused Technology
100,0
%
| 206 | 100,0 % | 167 | 100,0 % | -19,03% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 206 | 100,0 % | 167 | 100,0 % | -19,03% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joseph Payne
CEO | Chief Executive Officer | 52 | 01/03/13 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 01/01/19 |
Chief Operating Officer | 45 | 01/01/13 | |
Chief Tech/Sci/R&D Officer | 68 | 01/03/23 | |
Neda Safarzadeh
IRC | Investor Relations Contact | - | - |
Lance Kurata
LAW | General Counsel | 54 | 10/08/20 |
Kevin T. Skol
PRN | Corporate Officer/Principal | - | 01/01/02 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Edward Holmes
BRD | Director/Board Member | 83 | 01/09/19 |
James Barlow
BRD | Director/Board Member | 65 | 27/05/18 |
Peter Farrell
CHM | Chairman | 81 | 27/05/18 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 01/01/19 |
Magda Marquet
BRD | Director/Board Member | 65 | 27/05/18 |
Jing Marantz
BRD | Director/Board Member | 58 | 07/12/21 |
Joseph Payne
CEO | Chief Executive Officer | 52 | 01/03/13 |
John Markels
BRD | Director/Board Member | 58 | 08/12/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 26 931 826 | 24 640 838 ( 91,49 %) | 0 | 91,49 % |
Coordinate società
Arcturus Therapeutics Holdings, Inc.
10628 Science Center Drive Suite 250
92121, San Diego
+
http://www.arcturusrx.com![Indirizzo Arcturus Therapeutics Holdings Inc.(ARCT)](https://cdn.zonebourse.com/static/address/62745704.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-30,03% | 581 Mln | |
+16,81% | 44,63 Mrd | |
+43,23% | 40,46 Mrd | |
-9,25% | 38,07 Mrd | |
+33,10% | 32,27 Mrd | |
-8,98% | 27,3 Mrd | |
+13,84% | 26,53 Mrd | |
+46,61% | 14,06 Mrd | |
+31,05% | 12,54 Mrd | |
-8,61% | 11,28 Mrd |
- Borsa valori
- Azioni
- Azione ARCT
- Società Arcturus Therapeutics Holdings Inc.